tiprankstipranks
Vertex Pharmaceuticals (IT:1VRTX)
:1VRTX
Italy Market

Vertex Pharmaceuticals (1VRTX) Technical Analysis

4 Followers

Summary of all the Indicators

Overall Consensus
Strong Buy
11Bullish
0Neutral
2Bearish
Technical Analysis Consensus
Strong Sell
0Bullish
0Neutral
1Bearish
Moving Average Consensus
Strong Buy
11Bullish
0Neutral
1Bearish
Vertex Pharmaceuticals’s (1VRTX) Moving Averages Convergence Divergence (MACD) indicator is 3.91, suggesting Vertex Pharmaceuticals is a Buy.
Vertex Pharmaceuticals’s (1VRTX) 20-Day exponential moving average is 423.25, while Vertex Pharmaceuticals’s (1VRTX) share price is €425.35, making it a Buy.
Vertex Pharmaceuticals’s (1VRTX) 50-Day exponential moving average is 412.26, while Vertex Pharmaceuticals’s (1VRTX) share price is €425.35, making it a Buy.

Vertex Pharmaceuticals (1VRTX) Pivot Points

Jul 30, 2026, 01:29 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
Fibonacci
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Vertex Pharmaceuticals (1VRTX) Moving Averages

Jul 30, 2026, 01:29 PM
Period
Simple
Exponential
MA5
421.61Buy
423.63Buy
MA10
422.01Buy
423.78Buy
MA20
430.95Sell
423.25Buy
MA50
407.06Buy
412.26Buy
MA100
394.69Buy
401.05Buy
MA200
389.51Buy
387.52Buy
Vertex Pharmaceuticals’s (1VRTX) 10-Day exponential moving average is 423.78, while Vertex Pharmaceuticals’s (1VRTX) share price is €425.35, making it a Buy.
Vertex Pharmaceuticals’s (1VRTX) 100-Day exponential moving average is 401.05, while Vertex Pharmaceuticals’s (1VRTX) share price is €425.35, making it a Buy.
Vertex Pharmaceuticals’s (1VRTX) stock price is €425.35 and Vertex Pharmaceuticals’s (1VRTX) 50-day simple moving average is 407.06, creating a Buy signal.
Vertex Pharmaceuticals’s (1VRTX) stock price is €425.35 and Vertex Pharmaceuticals’s (1VRTX) 100-day simple moving average is 394.69, creating a Buy signal.
Vertex Pharmaceuticals’s (1VRTX) stock price is €425.35 and Vertex Pharmaceuticals’s (1VRTX) 200-day simple moving average is 389.51, creating a Buy signal.

Vertex Pharmaceuticals (1VRTX) Technical Indicators

Jul 30, 2026, 01:29 PM
Name
Value
Implied Action
RSI (14)
47.47
Neutral
STOCH (9,6)
23.64
Neutral
STOCHRSI (14)
12.04
Buy
MACD (12,26)
3.91
Buy
ADX (14)
21.23
Neutral
Williams %R
-96.18
Buy
CCI (14)
-90.16
Neutral
ATR (14)
6.87
-
Ultimate Oscillator
40.84
Neutral
ROC
-4.92
Sell
Vertex Pharmaceuticals’s (1VRTX) Relative Strength Index (RSI) is 47.47, creating a Neutral signal.
Vertex Pharmaceuticals’s (1VRTX) Trend Strength Indicator (ADX) is 21.23, creating a Neutral signal.
Vertex Pharmaceuticals’s (1VRTX) Commodity Channel Index (CCI) is -90.16, creating a Neutral signal.
Vertex Pharmaceuticals’s (1VRTX) Price Rate of Change (ROC) is -4.92, creating a Sell signal.

FAQ

Is 1VRTX a Buy, Hold, or Sell?
Based on 1VRTX’s technical indicators, 1VRTX is a Strong Buy.
    What is 1VRTX’s RSI (14)?
    1VRTX’s RSI (14) is 47.47, which suggests 1VRTX is a Neutral.
      What is 1VRTX’s MACD?
      1VRTX’s MACD is 3.91, which suggests 1VRTX is a Buy.
        What is 1VRTX’s 5-day moving average?
        1VRTX’s 5-day moving average is 421.61, which suggests 1VRTX is a Buy.
          What is 1VRTX’s 20-day moving average?
          1VRTX 20-day moving average is 430.95, which suggests 1VRTX is a Sell.
            What is 1VRTX’s 50-day moving average?
            1VRTX’s 50-day moving average is 407.06, which suggests 1VRTX is a Buy.
              What is 1VRTX’s 200-day moving average?
              1VRTX’s 200-day moving average is 389.51, which suggests 1VRTX is a Buy.
                What is 1VRTX’s Williams % R (14)?
                1VRTX’s Williams % R (14) is -96.18, which suggests 1VRTX is a Buy.
                  What is 1VRTX’s CCI (14)?
                  1VRTX’s CCI (14) is -90.16, which suggests 1VRTX is a Neutral.
                    What is the share price of Vertex Pharmaceuticals?